NICOX (EPA:COX) | WebDisclosure

Basculer en Français

10719	Companies
229667	Keywords
158192	Articles
121976	Press releases

Home
Companies
NICOX

PRESS RELEASE

published on 04/20/2026 at 07:30, 2 months 24 days ago

Rappel : le dernier jour d’exercice pour les Bons de Souscription d’Actions (BSA) Nicox de juin 2024 est le 19 juin 2026
Nicox rappelle la date limite d'exercice des Bons de Souscription d'Actions de juin 2024 au 19/06/2026. Détails sur les BSA et modalités d'exercice disponibles sur www.nicox.com

Euronext Growth Ophtalmologie Nicox Exercice BSA
BRIEF

published on 02/24/2026 at 07:35, 4 months 18 days ago

Nicox dévoile des résultats positifs de phase 3 pour le NCX 470 lors du congrès de l'AGS

Étude De Phase 3 NCX 470 Glaucome Pression Intraoculaire Profil Thérapeutique
BRIEF

published on 02/24/2026 at 07:35, 4 months 18 days ago

Nicox Reveals Positive Phase 3 Results for NCX 470 at AGS Meeting

Glaucoma Phase 3 Study NCX 470 Intraocular Pressure Therapeutic Profile
PRESS RELEASE

published on 02/24/2026 at 07:30, 4 months 18 days ago

Nicox présente des données de Phase 3 positives confirmant le profil thérapeutique de NCX 470 lors du congrès annuel 2026 de l’American Glaucoma Society (AGS)
Nicox présente des données de Phase 3 positives pour NCX 470 au congrès annuel 2026 de l'AGS, démontrant une réduction significative de la pression intraoculaire

Phase 3 Nicox NCX 470 Pression Intraoculaire Congrès AGS
PRESS RELEASE

published on 02/24/2026 at 07:30, 4 months 18 days ago

Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting
Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting

Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
BRIEF

published on 02/16/2026 at 07:35, 4 months 26 days ago

Nicox prépare une soumission de NDA pour NCX 470 après avis positif de la FDA

FDA NDA Nicox NCX 470 Glaucome
BRIEF

published on 02/16/2026 at 07:35, 4 months 26 days ago

Nicox Receives Positive Feedback from FDA for NCX 470 NDA

FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
BRIEF

published on 02/16/2026 at 07:35, 4 months 26 days ago

Nicox reçoit un avis favorable de la FDA concernant sa demande d'autorisation de mise sur le marché (NDA) pour le NCX 470.

FDA Nicox Traitement Du Glaucome NCX 470 Soumission D'un Accord De Confidentialité
BRIEF

published on 02/16/2026 at 07:35, 4 months 26 days ago

Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion

FDA Glaucoma NDA Nicox NCX 470
PRESS RELEASE

published on 02/16/2026 at 07:30, 4 months 26 days ago

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470
Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients

FDA Nicox NCX 470 Intraocular Pressure Pre-NDA

Accesswire

Published on 07/14/2026 at 16:40, 5 hours 42 minutes ago

AIAI Holdings' MediGuide Enters the State-of-the-Art Medicine Market With AI-Driven Innovation
Published on 07/14/2026 at 15:45, 6 hours 37 minutes ago

Silver Storm Commences Hot Commissioning of the La Parrilla Sulphide Circuit, Amends the Samsung Prepayment Agreement, and Secures US$5 Million Loan from First Majestic
Published on 07/14/2026 at 15:15, 7 hours 7 minutes ago

Gratomic Inc. Provides Corporate Update for Shareholders
Published on 07/14/2026 at 15:00, 7 hours 22 minutes ago

Four Nines Gold Engages Drill Contractor as Hayden Hill Enters First Modern Drill Campaign in Nearly Three Decades
Published on 07/14/2026 at 14:00, 8 hours 22 minutes ago

First Canadian Graphite Appoints Tony La Mantia to Advisory Board

View all ACCESSWIRE

EQS Group

Published on 07/14/2026 at 19:14, 3 hours 8 minutes ago

EQS-Adhoc: Nagarro SE: BaFin Enforcement Review of the 2022 Consolidated Financial Statements
Published on 07/14/2026 at 18:17, 4 hours 5 minutes ago

EQS-Adhoc: Delivery Hero confirms advanced negotiations with Uber Technologies in respect to potential takeover offer
Published on 07/14/2026 at 17:51, 4 hours 31 minutes ago

Aumann announces share buyback with an allotment ratio of approximately 6%
Published on 07/14/2026 at 17:30, 4 hours 52 minutes ago

NABR: The U.S. Fish and Wildlife Service for the Second Time Rejects Activists' Petition to List Long-Tailed Macaque Monkeys Under the Endangered Species Act
Published on 07/14/2026 at 17:28, 4 hours 54 minutes ago

Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets

Les Echos

Published on 07/13/2026 at 18:00, 1 day 4 hours ago

CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago

PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 1 day 4 hours ago

THERMADOR GROUPE : 2026 half-year turnover
Published on 07/13/2026 at 18:00, 1 day 4 hours ago

THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
Published on 07/13/2026 at 17:45, 1 day 4 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE